Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lemaitre Vascular (LMAT)
NASDAQ:LMAT
Lemaitre Vascular (LMAT) Stock Price & Analysis
181 Followers
LMAT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$44.04 - $74.46
Previous Close$64.12
Volume54.23K
Average Volume (3M)117.04K
Market Cap
$1.44B
Enterprise Value$1.36B
Total Cash (Recent Filing)$97.02M
Total Debt (Recent Filing)$16.88M
Price to Earnings (P/E)48.0
Beta0.47
Next Earnings
May 01, 2024EPS Estimate
$0.39Next Dividend Ex-DateN/A
Dividend Yield0.9%
Share Statistics
EPS (TTM)1.34
Shares Outstanding22,337,216
10 Day Avg. Volume99,823
30 Day Avg. Volume117,041
Standard Deviation0.09
R-Squared0.23
Alpha0.00785
Financial Highlights & Ratios
Price to Book (P/B)7.57
Price to Sales (P/S)8.86
Price to Cash Flow (P/CF)33.50
P/FCF Ratio33.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.33
Enterprise Value/Gross Profit12.96
Enterprise Value/Ebitda30.30
Forecast
1Y Price Target
$69.00Price Target Upside7.61% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Lemaitre Vascular News
Ownership Overview
30.88% Insiders
26.81% Mutual Funds
24.94% Other Institutional Investors
17.37% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
LMAT FAQ
What was Lemaitre Vascular’s price range in the past 12 months?
Lemaitre Vascular lowest stock price was $44.04 and its highest was $74.46 in the past 12 months.
What is Lemaitre Vascular’s market cap?
Currently, no data Available
When is Lemaitre Vascular’s upcoming earnings report date?
Lemaitre Vascular’s upcoming earnings report date is May 01, 2024 which is in 12 days.
How were Lemaitre Vascular’s earnings last quarter?
Lemaitre Vascular released its earnings results on Feb 27, 2024. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.356 by $0.024.
Is Lemaitre Vascular overvalued?
According to Wall Street analysts Lemaitre Vascular’s price is currently Undervalued.
Does Lemaitre Vascular pay dividends?
Lemaitre Vascular does not currently pay dividends.
What is Lemaitre Vascular’s EPS estimate?
Lemaitre Vascular’s EPS estimate is $0.39.
How many shares outstanding does Lemaitre Vascular have?
Lemaitre Vascular has 22,337,215 shares outstanding.
What happened to Lemaitre Vascular’s price movement after its last earnings report?
Lemaitre Vascular reported an EPS of $0.38 in its last earnings report, beating expectations of $0.356. Following the earnings report the stock price went up 14.413%.
Which hedge fund is a major shareholder of Lemaitre Vascular?
Among the largest hedge funds holding Lemaitre Vascular’s share is Driehaus Capital Management LLC. It holds Lemaitre Vascular’s shares valued at 6M.
---
Lemaitre Vascular Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$69.00 (7.61% Upside)
$69.00 (7.61% Upside)
Blogger Sentiment
Bullish
LMAT Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 16.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $462.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
23.12%
12-Months-Change
Fundamentals
Return on Equity
10.64%
Trailing 12-Months
Asset Growth
11.69%
Trailing 12-Months
Company Description
Lemaitre Vascular
LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.
---
LMAT Company Deck
---
LMAT Earnings Call
Q4 2024
0:00 / 0:00
---
LMAT Stock 12 Months Forecast
Average Price Target
$69.00
▲(7.61% Upside)
Technical Analysis
Best Analysts Covering LMAT
1 Year
1 Year Success Rate
15/28 ratings generated profit
1 Year Average Return
+16.27%
reiterated a buy rating 2 months ago
Copying Michael Petusky's trades and holding each position for 1 Year would result in 53.57% of your transactions generating a profit, with an average return of +16.27% per trade.
---